Asset Details
Do you wish to reserve the book?
Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid Carcinoma
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid Carcinoma
Do you wish to request the book?
Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid Carcinoma
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid Carcinoma
1997
Overview
Thyroid carcinoma is diagnosed in 14,000 people each year in the United States.
1
Most are effectively treated by surgery, followed often by radioiodine therapy and always by thyroid hormone therapy to suppress the secretion of thyrotropin. These patients require monitoring for recurrence of tumor, which can occur decades later.
2
,
3
In some patients, monitoring includes periodic discontinuation of thyroid hormone therapy for radioiodine scanning
4
,
5
and measurement of serum thyroglobulin
6
,
7
to detect residual or recurrent thyroid carcinoma. As a consequence of discontinuing thyroid hormone therapy, patients typically have symptomatic hypothyroidism, some may not have a sufficient increase in thyrotropin . . .
Publisher
Massachusetts Medical Society
Subject
/ Aged
/ Biological and medical sciences
/ Diabetes
/ Female
/ Hormones
/ Humans
/ Iodine Radioisotopes - pharmacokinetics
/ Male
/ Neoplasm Recurrence, Local - diagnostic imaging
/ Patients
/ Pharmacology. Drug treatments
/ Thyroid Hormones - therapeutic use
/ Thyroid Neoplasms - diagnostic imaging
/ Thyroid Neoplasms - drug therapy
/ Thyroid Neoplasms - metabolism
/ Thyrotropin - administration & dosage
